DE158973T1 - Multisites immunometrisches testverfahren. - Google Patents

Multisites immunometrisches testverfahren.

Info

Publication number
DE158973T1
DE158973T1 DE198585104365T DE85104365T DE158973T1 DE 158973 T1 DE158973 T1 DE 158973T1 DE 198585104365 T DE198585104365 T DE 198585104365T DE 85104365 T DE85104365 T DE 85104365T DE 158973 T1 DE158973 T1 DE 158973T1
Authority
DE
Germany
Prior art keywords
antibody
antigen
antibodies
complex
cell line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198585104365T
Other languages
German (de)
English (en)
Inventor
Dominique Bellet
Jack R Wands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
General Hospital Corp
Original Assignee
Institut Gustave Roussy (IGR)
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR), General Hospital Corp filed Critical Institut Gustave Roussy (IGR)
Publication of DE158973T1 publication Critical patent/DE158973T1/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5757—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofoetal proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE198585104365T 1984-04-12 1985-04-11 Multisites immunometrisches testverfahren. Pending DE158973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59956084A 1984-04-12 1984-04-12

Publications (1)

Publication Number Publication Date
DE158973T1 true DE158973T1 (de) 1987-01-15

Family

ID=24400127

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198585104365T Pending DE158973T1 (de) 1984-04-12 1985-04-11 Multisites immunometrisches testverfahren.
DE8585104365T Expired - Lifetime DE3579841D1 (de) 1984-04-12 1985-04-11 Multisites immunometrisches testverfahren.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8585104365T Expired - Lifetime DE3579841D1 (de) 1984-04-12 1985-04-11 Multisites immunometrisches testverfahren.

Country Status (6)

Country Link
EP (1) EP0158973B1 (cg-RX-API-DMAC7.html)
JP (1) JPS60259963A (cg-RX-API-DMAC7.html)
AT (1) ATE57018T1 (cg-RX-API-DMAC7.html)
DE (2) DE158973T1 (cg-RX-API-DMAC7.html)
DK (1) DK165785A (cg-RX-API-DMAC7.html)
GR (1) GR850899B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
EP0254081A3 (en) * 1986-06-30 1988-04-20 Yuko Yoneda Method of detecting specific protein
US4804626A (en) * 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
JP2515533B2 (ja) * 1987-02-23 1996-07-10 和光純薬工業株式会社 蛋白の定量方法
US5506150A (en) * 1987-07-09 1996-04-09 3I Research Exploitation Limited Prenatal screening for down's syndrome
EP0362294B1 (en) * 1987-07-09 1993-06-30 3i RESEARCH EXPLOITATION LIMITED Antenatal screening for down's syndrome
GB8821507D0 (en) * 1988-09-14 1988-10-12 Cancer Res Campaign Tech Improvements relating to peptides
ATE252240T1 (de) * 1989-01-17 2003-11-15 Jn Macri Technologies Llc Inc Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
DE59511054D1 (de) * 1994-07-25 2006-08-10 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
DE19534988A1 (de) * 1995-09-21 1997-03-27 Forssmann Wolf Georg Verfahren zur Herstellung und Anwendung synthetischer, biotinylierter Peptide
WO2000066787A2 (en) * 1999-05-05 2000-11-09 Ohio University Growth hormone-regulatable liver genes and proteins, and uses thereof
US7060437B1 (en) 1999-05-05 2006-06-13 Ohio University Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof
US6858389B1 (en) 1999-05-05 2005-02-22 Ohio University Growth hormone-regulatable liver genes and proteins, and uses thereof
US20030180967A1 (en) * 2002-03-19 2003-09-25 Matsushita Electric Industrial Co., Ltd. Immunoassay method, test strip for use therein, and immunoassay apparatus
JP5138867B2 (ja) * 2002-08-01 2013-02-06 イミューノメディクス、インコーポレイテッド α−フェトタンパク質Ｉｍｍｕ３１抗体および融合タンパク質ならびにその使用方法
FI20030747A0 (fi) 2003-05-19 2003-05-19 Orion Corp Toremifeenin kiteytysmenetelmä
CN105572358A (zh) * 2014-10-09 2016-05-11 苏州新波生物技术有限公司 乙型肝炎病毒e抗原定量检测试剂盒及其制备与检测方法
CN104714015B (zh) * 2014-10-28 2017-05-17 威海纽普生物技术有限公司 心型脂肪酸结合蛋白检测试剂盒及检测方法
CN104714025B (zh) * 2014-11-28 2017-05-17 威海纽普生物技术有限公司 NT‑proBNP检测试剂盒及检测方法
CN104714033B (zh) * 2014-11-28 2017-03-15 威海纽普生物技术有限公司 降钙素原检测试剂盒及检测方法
CN104730245B (zh) * 2014-11-28 2016-09-28 威海纽普生物技术有限公司 D二聚体检测试剂盒及检测方法
CN104730251B (zh) * 2014-11-28 2016-11-23 威海纽普生物技术有限公司 肌钙蛋白i检测试剂盒及检测方法
JP7068323B2 (ja) * 2017-02-02 2022-05-16 エフ．ホフマン－ラ ロシュ アーゲー 少なくとも２種のペグ化された分析物特異的結合剤を使用する免疫アッセイ
CN106970226A (zh) * 2017-03-22 2017-07-21 童坤 一种测定人血清中her‑2 ecd浓度水平的试剂盒
JP7432502B2 (ja) * 2017-09-22 2024-02-16 エフ． ホフマン－ラ ロシュ アーゲー 分析目的のための多価単一または二重特異性組換え抗体
JP7313659B2 (ja) * 2019-03-12 2023-07-25 株式会社シノテスト 試料中のｈｍｇｂ１の測定方法及び測定試薬
JP7639420B2 (ja) * 2021-03-16 2025-03-05 東ソー株式会社 パラチロイドホルモンの測定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
SE8006424L (sv) * 1980-09-12 1982-03-13 Jolla Cancer Res Found Sett att bestemma ett antigen i losning
JPS57136165A (en) * 1981-02-18 1982-08-23 Mochida Pharmaceut Co Ltd Immunological measuring reagent
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect

Also Published As

Publication number Publication date
DK165785D0 (da) 1985-04-12
DE3579841D1 (de) 1990-10-31
ATE57018T1 (de) 1990-10-15
EP0158973A2 (en) 1985-10-23
EP0158973B1 (en) 1990-09-26
JPS60259963A (ja) 1985-12-23
DK165785A (da) 1985-10-13
GR850899B (cg-RX-API-DMAC7.html) 1985-11-25
EP0158973A3 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
DE158973T1 (de) Multisites immunometrisches testverfahren.
DE3852040T2 (de) Vorrichtung und verfahren zur bestimmung einer komponente einer probe.
DE3781335T2 (de) Immunoassay mit verwendung von kolloidalem gold.
DE3872621T2 (de) Nachweis von umgebenden konzentrationen mehrerer analyten.
EP1536232B1 (de) Analytischer Sandwichtest zur Bestimmung von NT-proBNP
DE69624920T2 (de) Testreagentien und Testvorrichtungen
US7410768B2 (en) Test methods and devices
ATE117435T1 (de) Spezifische antikörper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von herzmuskelnekrosen.
EP0264219A3 (en) Receptors for immune complexes, their methods of production, compositions containing them, assay methods and assay kits using them
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE178097T1 (de) Monoklonale antikörper gegen den alpha-pdgf- rezeptor und deren verwendungen
DE69228418T2 (de) Nachweis von löslichen alloantigen-immunkomplexen
DE3834766A1 (de) Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
EP0356964A2 (de) Verfahren zur Bestimmung einer spezifisch bindefähigen Substanz
EP0291086A3 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten
GB2191577A (en) Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
EP0296544A2 (de) Immunometrisches Bestimmungsverfahren
EP2147313A2 (de) Verfahren zum nachweis spezifischer antikörper der immunglobulinklasse g
EP0829723A2 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
DE69520111T2 (de) Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen
EP0379216A1 (de) Verfahren und Reagenz zur Bestimmung von immunologisch nachweisbaren Substanzen
DE3836348A1 (de) Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz
EP0916948A3 (de) Verbessertes Verfahren zum Nachweis von PSA-ACT-Komplexen
DE102004052729A1 (de) Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten
DE3874741T2 (de) Immunassay-verfahren.